COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,300 Articles (22,772 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 889: Articles 8881-8890  | Next

Short-term drop in antibody titer after the third dose of SARS-CoV-2 BNT162b2 vaccine in adults
Herzberg, J., Fischer, B., Becher, H., Becker, A.-K., Honarpisheh, H., Strate, T., Knabbe, C.
10.1101/2022.03.07.22272028 — Posted: 2022-03-10
Trends, regional variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY
Green, A. C., Curtis, H. J., Higgins, R., Smith, R., Mehrkar, A., Inglesby, P., Mahalingasivam, V., Drysdale, H., DeVito, N., Croker, R., Rentsch, C. T., Bhaskaran, K., Andrews, C. D., Bacon, S. C., Davy, S., Dillingham, I., Evans, D., Fisher, L., Hickman, G., Hopcroft, L. E. M., Hulme, W. J., Massey, J., Morley, J., Morton, C. E., Park, R. Y., Walker, A. J., Ward, T., Wiedemann, M., Bates, C., Cockburn, J., Parry, J., Hester, F., Harper, S., Douglas, I. J., Evans, S. J., Tomlinson, L., MacKenna, B., Goldacre, B.
10.1101/2022.03.07.22272026 — Posted: 2022-03-10
Emergence and Spread of the SARS-CoV-2 Omicron Variant in Alberta Communities Revealed by Wastewater Monitoring
Hubert, C. R., Acosta, N., Waddell, B. J., Hasing, M. E., Qiu, Y., Fuzzen, M., Harper, N. B., Bautista, M. A., Gao, T., Papparis, C., Van Doorn, J., Du, K., Xiang, K., Chan, L., Vivas, L., Pradhan, P., McCalder, J., Low, K., England, W. E., Conly, J., Ryan, M. C., Achari, G., Hu, J., Cabaj, J. L., Sikora, C., Svenson, L., Zelyas, N., Servos, M., Meddings, J., Hrudey, S. E., Frankowski, K., Parkins, M. D., Pang, X., Lee, B. E.
10.1101/2022.03.07.22272055 — Posted: 2022-03-10
Reorganization of F-actin nanostructures is required for the late phases of SARS-CoV-2 replication in pulmonary cells.
Swain, J., Merida, P., Rubio, K., Bracquemond, D., Aguilar-Ordonez, I., Guenther, S., Barreto, G., Muriaux, D.
10.1101/2022.03.08.483451 — Posted: 2022-03-10
High-throughput molecular dynamics-based alchemical free energy calculations for predicting the binding free energy change associated with the common mutations in the spike receptor-binding domain of SARS-CoV-2
Bhadane, R. N., Salo-Ahen, O. M. H.
10.1101/2022.03.07.483402 — Posted: 2022-03-10
Is virtual care the new normal? Evidence supporting Covid-19's durable transformation on healthcare delivery
Mandal, S., Wiesenfeld, B., Mann, D. M., Lawrence, K., Chunara, R. M., Testa, P., Nov, O.
10.1101/2022.03.08.22272020 — Posted: 2022-03-09
Sustained high prevalence of COVID-19 deaths from a systematic post-mortem study in Lusaka, Zambia: one year later
Gill, C. J., Mwananyanda, L., MacLeod, W., Kwenda, G., Pieciak, R., Etter, L. E., Bridges, D., Chikot, C., Chirwa, S., Chimoga, C., Forman, L., Katowa, B., Lapidot, R., Lungu, J., Matoba, J., Mwinga, G., Mubemba, B., Mupila, Z., Muleya, W., Ngoma, B., Nakazwe, R., Nzara, D., Pawlak, N., Pemba, L., Simulundu, E., Yankonde, B., Thea, D. M.
10.1101/2022.03.08.22272087 — Posted: 2022-03-09
Boosters protect against SARS-CoV-2 infections in young adults during an Omicron-predominant period
Wan, J., Cazer, C. L., Clarkberg, M. E., Henderson, S. G., Lee, S. E., Meredith, G., Osman, M., Shmoys, D. B., Frazier, P. I.
10.1101/2022.03.08.22272056 — Posted: 2022-03-09
A systematic review and meta-analysis of Long COVID symptoms
Natarajan, A., Shetty, A., Delanerolle, G., Zeng, Y., Zhang, Y., Raymont, V., Rathod, S., Halabi, S., Elliot, K., Phiri, P., Shi, J. q.
10.1101/2022.03.08.22272091 — Posted: 2022-03-09
Impact of long-term COVID on workers: a systematic review protocol
do Prado, C. B., Emerick, G. S., Cevolani Pires, L. B., Salaroli, L. B.
10.1101/2022.03.07.22272051 — Posted: 2022-03-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).